查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1750820

中央研究實驗室市場規模、佔有率、趨勢分析報告：按服務、最終用途、地區、細分市場預測，2025-2030 年

Central Lab Market Size, Share & Trends Analysis Report By Service (Genetic Services, Biomarker Services, Microbiology Services), By End-use (Pharmaceutical Companies, Biotechnology Companies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

中央研究實驗室市場成長與趨勢：

根據Grand View Research, Inc.的最新報告，全球中央實驗室市場規模預計到2030年將達到50.4億美元，2025年至2030年的複合年成長率為6.56%。

中央實驗室業務外包是推動市場成長的關鍵因素。

中心業務營運外包是臨床試驗產業日益成長的趨勢，預計將為中心實驗室創造豐厚的商機。臨床實驗和申辦者將約80%的中心實驗室業務外包，並且更青睞能夠提供端到端一體化服務的實驗室。

近年來，由於疫情期間對製藥業的關注度增加，研發投入激增。隨著疫情進入第三年，科學研究投入增強了研發管線，多項臨床試驗也已啟動。疫情期間，介入性研究活動穩定擴展。製藥業開發了新的試驗交付方法，以便在疫情期間管理正在進行的臨床試驗。

疫情也帶來了新的成長機會，人們越來越關注 mRNA 疫苗的研發和 COVID-19治療方法的探索。然而，樣本處理、供應鏈和物流對於送到臨床實驗室的樣本至關重要。這些樣本高度敏感，需要快速的物流和溫控，以保持樣本的穩定性，以獲得最準確的結果。

中小型中心實驗室的興起加劇了全球競爭。中小型中心實驗室在亞太等開發中地區非常普遍。此外，新興經濟體進行臨床試驗的成本較低，這使得選擇位於這些地區的中心實驗室變得更加容易。這是因為它們的物流成本低，而且靠近施行地點。

中央研究實驗室市場報告重點

  • 由於基因分析在臨床試驗中的重要性日益增加，預計預測期內基因服務領域將以最快的複合年成長率成長。
  • 策略性收購是影響市場動態變化的因素之一。例如，中大型企業進行收購是為了加強其全球擴張或進入新業務領域。
  • 按最終用途分類，製藥公司在 2024 年佔據最大的市場佔有率，為 44.78%。
  • 由於糖尿病和癌症等疾病領域的個人化醫療相關的臨床試驗對基因檢測的需求不斷增加，預計到 2024 年北美將佔據全球市場的主導地位，佔有 40.82% 的佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場展望
    • 母市場展望
    • 相關/支持市場展望
  • 市場動態
  • 市場促進因素
    • 加大臨床試驗研發投入
    • 新藥需求不斷成長
    • 中央研究實驗室業務外包
    • 降低藥物研發成本
  • 市場限制因素分析
    • 物流和樣品處理
  • 商業環境分析
    • SWOT分析；按因素（政治/法律、經濟/技術）
    • 波特五力分析
    • COVID-19影響分析

第4章中央研究實驗室市場：按服務分類的估計和趨勢分析

  • 中央研究實驗室市場：服務波動分析
  • 遺傳學服務
    • 中央遺傳服務實驗室市場，2018-2030
  • 生物標誌服務
    • 生物標記服務中心實驗室市場（2018-2030）
  • 微生物學服務
    • 微生物學服務中心實驗室市場（2018-2030）
  • 解剖病理學/組織學
    • 解剖病理學/組織學中心實驗室市場（2018-2030）
  • 檢體管理與儲存
    • 2018-2030 年檢體管理與儲存中心實驗室市場
  • 特種化學品服務
    • 2018-2030 年特用化學品服務中心實驗室市場
  • 其他
    • 其他中央研究實驗室市場，2018-2030

第5章中央研究實驗室市場：按最終用途的估計和趨勢分析

  • 中央研究實驗室市場：最終用途趨勢分析
  • 製藥公司
    • 製藥公司市場，2018-2030
  • 生技公司
    • 生技公司市場，2018-2030
  • 學術研究所
    • 學術研究市場，2018-2030

第6章中央研究所市場：區域估計與趨勢分析

  • 2023 年及 2030 年中央研究實驗室各地區市場佔有率
  • 北美洲
    • 2018-2030年北美中央實驗室市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年歐洲中央實驗室市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太中心實驗室市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年拉丁美洲中央實驗室市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東與非洲中央研究實驗室市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 參與企業概況
  • 財務表現
  • 參與企業
    • 市場領導者
    • 中央研究實驗室市場佔有率分析，2023年
    • 公司簡介
Product Code: GVR-4-68039-962-2

Central Lab Market Growth & Trends:

The global central lab market size is estimated to reach USD 5.04 billion by 2030, registering a CAGR of 6.56% from 2025 to 2030, according to a new report by Grand View Research, Inc. The outsourcing of central lab work is a significant factor driving the market growth.

Outsourcing central lab work is a rising trend in the clinical trial industry, which is expected to create lucrative business opportunities for central labs. The investigators and sponsors outsource ~80% of the central lab work and prefer the labs that provide end-to-end integrated services.

Investment in R&D has witnessed a surge in past years, which can be attributed to the enhanced focus on the pharmaceutical industry during the pandemic. As we enter the third year of the pandemic, investment in science has enhanced the pipeline and several clinical trials have been initiated. Over the pandemic, activity in interventional studies grew steadily. The pharmaceutical industry developed a new way of conducting trials for the management of ongoing clinical trials during the pandemic.

The pandemic has also created new growth opportunities, with an increasing focus on mRNA vaccine development and investigations for several COVID-19 treatment options. However, sample handling, supply chain, and logistics play a significant role in the sample sent to clinical labs. These samples are highly sensitive and require fast logistics with temperature control, thereby maintaining sample stability to get the most accurate results.

The rise of small- and medium-scale central laboratories is intensifying the competition globally. The presence of small- and medium-scale central labs is highly prominent in developing regions such as the Asia Pacific. These laboratories are becoming critical in the management of clinical trials globally owing to the availability of central laboratory services at 20%-35% lower prices, when compared to Europe and the U.S. Furthermore, the lower cost of conducting clinical trials in the developing economies facilitates the selection of central laboratories present in these regions, which can be attributed to lower logistic costs and presence near the trial location.

Central Lab Market Report Highlights:

  • The genetic services segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the increasing significance of genetic analysis in clinical studies.
  • Strategic acquisitions are one of the factors influencing the changing dynamics of the market. For instance, players are acquired by medium and large-scale enterprises for enhancing their global reach and entering new business segments.
  • By end-use, the pharmaceutical companies held the largest market share of 44.78% in 2024, attributable to an increasing number of interventional studies and investment into research.
  • North America dominated the global market in 2024 with a share of 40.82%, the increasing need for genetic testing in clinical trials related to personalized healthcare in disease areas, such as diabetes & cancers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Service Outlook
    • 2.2.2. End Use Outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Rising R&D investment in clinical trial
    • 3.4.2. Escalating demand for novel drugs
    • 3.4.3. Outsourcing of central lab work
    • 3.4.4. Reducing the cost of drug research
  • 3.5. Market Restraint Analysis
    • 3.5.1. Logistics and sample handling
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Central Labs Market: Service Estimates & Trend Analysis

  • 4.1. Central Lab Market: Service Movement Analysis
  • 4.2. Genetic Services
    • 4.2.1. Genetic Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.3. Biomarker Services
    • 4.3.1. Biomarker Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.4. Microbiology Services
    • 4.4.1. Microbiology Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.5. Anatomic Pathology/Histology
    • 4.5.1. Anatomic Pathology/Histology Central Lab Market, 2018 - 2030 (USD Million)
  • 4.6. Specimen Management and Storage
    • 4.6.1. Specimen Management and Storage Central Lab Market, 2018 - 2030 (USD Million)
  • 4.7. Special Chemistry Services
    • 4.7.1. Special Chemistry Services Central Lab Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Central Lab Market, 2018 - 2030 (USD Million)

Chapter 5. Central Labs Market: End Use Estimates & Trend Analysis

  • 5.1. Central Lab Market: End-Use Movement Analysis
  • 5.2. Pharmaceutical Companies
    • 5.2.1. Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
  • 5.3. Biotechnology Companies
    • 5.3.1. Biotechnology Companies Market, 2018 - 2030 (USD Million)
  • 5.4. Academic and Research Institutes
    • 5.4.1. Academic and Research Institutes Market, 2018 - 2030 (USD Million)

Chapter 6. Central Lab Market: Regional Estimates & Trend Analysis

  • 6.1. Central Lab Market Share By Region, 2023 & 2030
  • 6.2. North America
    • 6.2.1. North America Central lab market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Reimbursement Scenario
      • 6.2.2.5. U.S. Central lab market, 2018 - 2030 (USD MILLION)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Reimbursement Scenario
      • 6.2.3.5. Canada Central lab market, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Competitive Scenario
      • 6.2.4.3. Regulatory Framework
      • 6.2.4.4. Reimbursement Scenario
      • 6.2.4.5. Mexico Central lab market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Central lab market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Reimbursement Scenario
      • 6.3.2.5. Germany Central lab market, 2018 - 2030 (USD Million)
    • 6.3.3. UK
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Reimbursement Scenario
      • 6.3.3.5. UK Central lab market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Reimbursement Scenario
      • 6.3.4.5. France Central lab market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Reimbursement Scenario
      • 6.3.5.5. Italy Central lab market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Reimbursement Scenario
      • 6.3.6.5. Spain Central lab market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Reimbursement Scenario
      • 6.3.7.5. Denmark Central lab market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Reimbursement Scenario
      • 6.3.8.5. Sweden Central lab market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Reimbursement Scenario
      • 6.3.9.5. Norway Central lab market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Central lab market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Scenario
      • 6.4.2.5. Japan Central lab market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Scenario
      • 6.4.3.5. China Central lab market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
      • 6.4.4.5. Reimbursement Scenario
      • 6.4.4.6. India Central lab market, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Reimbursement Scenario
      • 6.4.5.5. South Korea Central lab market, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Reimbursement Scenario
      • 6.4.6.5. Australia Central lab market, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Reimbursement Scenario
      • 6.4.7.5. Thailand Central lab market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Central lab market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Scenario
      • 6.5.2.5. Brazil Central lab market, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Scenario
      • 6.5.3.5. Argentina Central lab market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Central lab market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Scenario
      • 6.6.2.5. South Africa Central lab market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Scenario
      • 6.6.3.5. Saudi Arabia Central lab market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Scenario
      • 6.6.4.5. UAE Central lab market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Scenario
      • 6.6.5.5. Kuwait Central lab market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant's overview
  • 7.2. Financial performance
  • 7.3. Participant categorization
    • 7.3.1. Market Leaders
    • 7.3.2. Central Lab Market Share Analysis, 2023
    • 7.3.3. Company Profiles
      • 7.3.3.1. ACM Global Laboratories
        • 7.3.3.1.1. Company Overview
        • 7.3.3.1.2. Financial Performance
        • 7.3.3.1.3. Product Benchmarking
        • 7.3.3.1.4. Strategic Initiatives
      • 7.3.3.2. LabConnect
        • 7.3.3.2.1. Company Overview
        • 7.3.3.2.2. Financial Performance
        • 7.3.3.2.3. Product Benchmarking
        • 7.3.3.2.4. Strategic Initiatives
      • 7.3.3.3. Cerba Research
        • 7.3.3.3.1. Company Overview
        • 7.3.3.3.2. Financial Performance
        • 7.3.3.3.3. Product Benchmarking
        • 7.3.3.3.4. Strategic Initiatives
      • 7.3.3.4. Eurofins Scientific
        • 7.3.3.4.1. Company Overview
        • 7.3.3.4.2. Financial Performance
        • 7.3.3.4.3. Product Benchmarking
        • 7.3.3.4.4. Strategic Initiatives
      • 7.3.3.5. Versiti (Cenetron)
        • 7.3.3.5.1. Company Overview
        • 7.3.3.5.2. Financial Performance
        • 7.3.3.5.3. Product Benchmarking
        • 7.3.3.5.4. Strategic Initiatives
      • 7.3.3.6. Medicover Integrated Clinical Services (MICS) (Synevo Central Labs)
        • 7.3.3.6.1. Company Overview
        • 7.3.3.6.2. Financial Performance
        • 7.3.3.6.3. Product Benchmarking
        • 7.3.3.6.4. Strategic Initiatives
      • 7.3.3.7. A.P. Moller Holding A/S (Unilabs)
        • 7.3.3.7.1. Company Overview
        • 7.3.3.7.2. Financial Performance
        • 7.3.3.7.3. Product Benchmarking
        • 7.3.3.7.4. Strategic Initiatives
      • 7.3.3.8. Ampersand Capital Partners (Pacific Biomarkers)
        • 7.3.3.8.1. Company Overview
        • 7.3.3.8.2. Financial Performance
        • 7.3.3.8.3. Product Benchmarking
        • 7.3.3.8.4. Strategic Initiatives
      • 7.3.3.9. Lambda Therapeutic Research Ltd
        • 7.3.3.9.1. Company Overview
        • 7.3.3.9.2. Financial Performance
        • 7.3.3.9.3. Product Benchmarking
        • 7.3.3.9.4. Strategic Initiatives
      • 7.3.3.10. CIRION BioPharma Research Inc.
        • 7.3.3.10.1. Company Overview
        • 7.3.3.10.2. Financial Performance
        • 7.3.3.10.3. Product Benchmarking
        • 7.3.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 3 Global Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 4 Global Central Lab Market, by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 7 North America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 9 U.S. Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 10 Canada Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 11 Canada Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 13 Mexico Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Europe Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 16 Europe Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 17 Germany Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 18 Germany Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 20 UK Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 21 France Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 22 France Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 23 Italy Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 24 Italy Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Spain Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 26 Spain Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Denmark Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 28 Denmark Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Sweden Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 30 Sweden Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Norway Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 32 Norway Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 China Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 37 China Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 38 Japan Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 39 Japan Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 India Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 41 India Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 42 South Korea Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 43 South Korea Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 44 Australia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 45 Australia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Thailand Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 47 Thailand Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 48 Latin America Central Lab Market, by Country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 50 Latin America Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Brazil Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 52 Brazil Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 53 Argentina Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 54 Argentina Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 57 South Africa Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 58 South Africa Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 UAE Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 62 UAE Central Lab Market, by End Use, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Central Lab Market, by Service, 2018 - 2030 (USD Million)
  • Table 64 Kuwait Central Lab Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Central Lab Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Central Lab Market: Service Movement Analysis
  • Fig. 15 Global Central Lab Market, by Genetic Services, 2018 - 2030 (USD Million)
  • Fig. 16 Global Central Lab Market, by Biomarker Services, 2018 - 2030 (USD Million)
  • Fig. 17 Global Central Lab Market, by Anatomic Pathology/Histology, 2018 - 2030 (USD Million)
  • Fig. 18 Global Central Lab Market, by Specimen Management & Storage, 2018 - 2030 (USD Million)
  • Fig. 19 Global Central Lab Market, by Special Chemistry Services, 2018 - 2030 (USD Million)
  • Fig. 20 Global Central Lab Market, by Others, 2018 - 2030 (USD Million)
  • Fig. 21 Global Central Lab Market: End Use Movement Analysis
  • Fig. 22 Global Central Lab Market, by Pharmaceutical Companies 2018 - 2030 (USD Million)
  • Fig. 23 Global Central Lab Market, by Biotechnology Companies 2018 - 2030 (USD Million)
  • Fig. 24 Global Central Lab Market, by Academic & Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 Regional Marketplace: Key Takeaways
  • Fig. 26 Regional Outlook, 2023 & 2030
  • Fig. 27 Global Central Lab Market: Region Movement Analysis
  • Fig. 28 North America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 32 Europe Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 33 Germany Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 34 UK Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 35 France Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 36 Italy Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 37 Spain Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 38 Denmark Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 40 Norway Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 42 Japan Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 43 China Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 44 India Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 45 Australia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Central Lab Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Central Lab Market, 2018 - 2030 (USD Million)